Several small case-control studies have applied regression analyses to examine whether carriers of single thrombophilia gene polymorphisms, including Factor V Leiden (rs6025) and Prothrombin G20210A (rs1799963), are at increased risk of cancer.60 This evidence concerns the gene F5 and cancer.